Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
AK078587
| |
AK078587 |
11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030411M21 product:unclassifiable, full insert sequence [AK078587] |
KLA | 1.37 |
1.28 |
1.13 |
1.06 |
1.15 |
1.31 |
1.22 |
| ATP | 1.04 |
1.08 |
1.21 |
1.22 |
1.27 |
1.12 |
1.14 |
| KLA/ATP | 1.48 |
1.66 |
1.97 |
1.26 |
1.17 |
1.03 |
1.28 |
|
Aadacl1 | |
NM_178772 |
arylacetamide deacetylase-like 1 (Aadacl1), mRNA [NM_178772] |
KLA | .37 |
.32 |
.27 |
.24 |
.23 |
.38 |
.56 |
| ATP | 1.07 |
1.07 |
1.06 |
.70 |
1.03 |
.51 |
.95 |
| KLA/ATP | .31 |
.33 |
.33 |
.28 |
.67 |
.73 |
.41 |
|
Abcb11 | |
NM_021022 |
ATP-binding cassette, sub-family B (MDR/TAP), member 11 (Abcb11), mRNA [NM_021022] |
KLA | 1.01 |
.93 |
1.04 |
.97 |
.97 |
1.00 |
.97 |
| ATP | 1.00 |
.94 |
.97 |
1.05 |
.94 |
.92 |
.95 |
| KLA/ATP | 1.04 |
.96 |
1.03 |
.95 |
.95 |
1.01 |
.99 |
|
Abcb1a | |
NM_011076 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A (Abcb1a), mRNA [NM_011076] |
KLA | 1.24 |
1.32 |
1.51 |
1.43 |
1.41 |
1.20 |
.95 |
| ATP | 1.00 |
1.02 |
1.03 |
1.04 |
1.10 |
1.47 |
1.06 |
| KLA/ATP | 1.26 |
1.26 |
1.14 |
1.16 |
1.19 |
1.39 |
1.13 |
|
Abcb1b | |
NM_011075 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1B (Abcb1b), mRNA [NM_011075] |
KLA | 1.67 |
1.61 |
1.50 |
1.08 |
.67 |
.40 |
.31 |
| ATP | 1.09 |
1.32 |
1.19 |
1.68 |
1.23 |
.95 |
.34 |
| KLA/ATP | 1.63 |
1.89 |
1.85 |
2.17 |
1.07 |
.58 |
.27 |
|
Abcb4 | |
NM_008830 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 (Abcb4), mRNA [NM_008830] |
KLA | .81 |
.82 |
.69 |
.53 |
.35 |
.24 |
.19 |
| ATP | .98 |
1.03 |
1.08 |
1.05 |
.91 |
.74 |
.65 |
| KLA/ATP | .82 |
.87 |
.83 |
.82 |
.68 |
.39 |
.28 |
|
Abcc2 | |
NM_013806 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 (Abcc2), mRNA [NM_013806] |
KLA | .94 |
.94 |
.91 |
.92 |
.92 |
.93 |
.88 |
| ATP | 1.01 |
1.00 |
1.05 |
.94 |
.95 |
1.22 |
1.18 |
| KLA/ATP | .98 |
.94 |
.92 |
.93 |
1.01 |
1.47 |
1.43 |
|
Abcc3 | |
NM_029600 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 (Abcc3), mRNA [NM_029600] |
KLA | .79 |
.78 |
.76 |
.67 |
.54 |
.53 |
.79 |
| ATP | .93 |
.99 |
1.01 |
.89 |
.69 |
.55 |
1.11 |
| KLA/ATP | .83 |
.83 |
.78 |
.67 |
.51 |
.47 |
.70 |
|
Abcc4 | |
NM_001033336 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 (Abcc4), mRNA [NM_001033336] |
KLA | 1.11 |
1.06 |
1.18 |
1.10 |
1.17 |
1.12 |
.82 |
| ATP | 1.13 |
.92 |
1.28 |
.92 |
.75 |
1.55 |
.40 |
| KLA/ATP | 1.09 |
1.11 |
1.42 |
.93 |
.65 |
.64 |
.40 |
|
Abcg2 | |
NM_011920 |
ATP-binding cassette, sub-family G (WHITE), member 2 (Abcg2), mRNA [NM_011920] |
KLA | .80 |
.82 |
.76 |
.68 |
.58 |
.52 |
.62 |
| ATP | .95 |
.94 |
.94 |
.91 |
.68 |
.39 |
.38 |
| KLA/ATP | .83 |
.81 |
.72 |
.73 |
.54 |
.39 |
.27 |
|
Abcg5 | |
NM_031884 |
ATP-binding cassette, sub-family G (WHITE), member 5 (Abcg5), mRNA [NM_031884] |
KLA | 1.03 |
1.03 |
1.03 |
1.03 |
.98 |
.94 |
.99 |
| ATP | 1.14 |
.98 |
.96 |
.94 |
1.04 |
.99 |
.96 |
| KLA/ATP | .98 |
1.00 |
.99 |
.92 |
.91 |
1.04 |
1.03 |
|
Abcg8 | |
NM_026180 |
ATP-binding cassette, sub-family G (WHITE), member 8 (Abcg8), mRNA [NM_026180] |
KLA | 1.01 |
1.03 |
1.03 |
.99 |
1.02 |
1.06 |
.98 |
| ATP | .99 |
1.00 |
1.01 |
1.00 |
.97 |
1.04 |
1.05 |
| KLA/ATP | .98 |
.94 |
1.06 |
1.01 |
.99 |
.98 |
1.08 |
|
Adcy1 | |
BC050125 |
adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] |
KLA | 1.05 |
1.03 |
.98 |
1.04 |
1.05 |
1.09 |
1.10 |
| ATP | .90 |
1.02 |
.99 |
.97 |
1.03 |
.95 |
1.01 |
| KLA/ATP | .99 |
1.04 |
.90 |
.98 |
.98 |
1.00 |
1.03 |
|
Adcy1 | |
NM_009622 |
adenylate cyclase 1 (Adcy1), mRNA [NM_009622] |
KLA | 1.07 |
1.02 |
1.06 |
1.07 |
1.03 |
1.02 |
1.01 |
| ATP | 1.02 |
1.04 |
1.00 |
.99 |
.99 |
.95 |
.97 |
| KLA/ATP | .97 |
1.05 |
1.02 |
1.05 |
1.01 |
.98 |
1.05 |
|
Adcy2 | |
NM_153534 |
adenylate cyclase 2 (Adcy2), mRNA [NM_153534] |
KLA | .79 |
.82 |
.83 |
.73 |
.61 |
.66 |
.90 |
| ATP | 1.10 |
1.09 |
1.02 |
1.04 |
.88 |
.58 |
.53 |
| KLA/ATP | .84 |
.87 |
.77 |
.75 |
.68 |
.60 |
.43 |
|
Adcy3 | |
NM_138305 |
adenylate cyclase 3 (Adcy3), mRNA [NM_138305] |
KLA | .84 |
.84 |
.83 |
.78 |
.66 |
.55 |
.49 |
| ATP | 1.09 |
1.05 |
.89 |
1.02 |
.84 |
.62 |
1.52 |
| KLA/ATP | .93 |
.87 |
.75 |
.85 |
.66 |
.83 |
.77 |
|
Adcy4 | |
NM_080435 |
adenylate cyclase 4 (Adcy4), mRNA [NM_080435] |
KLA | 1.05 |
1.07 |
.96 |
1.00 |
1.04 |
1.05 |
1.05 |
| ATP | 1.02 |
1.05 |
1.02 |
1.48 |
1.37 |
1.08 |
1.09 |
| KLA/ATP | 1.00 |
1.05 |
.91 |
1.19 |
1.35 |
1.27 |
1.08 |
|
Adcy5 | |
NM_001012765 |
adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] |
KLA | 1.06 |
1.00 |
.97 |
1.01 |
1.03 |
.95 |
.93 |
| ATP | .95 |
1.08 |
1.08 |
1.07 |
.97 |
1.03 |
.97 |
| KLA/ATP | .97 |
.92 |
1.04 |
.99 |
.91 |
.96 |
1.04 |
|
Adcy6 | |
NM_007405 |
adenylate cyclase 6 (Adcy6), mRNA [NM_007405] |
KLA | 1.10 |
1.16 |
1.16 |
1.09 |
1.08 |
1.06 |
.99 |
| ATP | 1.05 |
.97 |
1.08 |
1.12 |
1.08 |
1.08 |
1.04 |
| KLA/ATP | 1.14 |
1.20 |
1.29 |
1.30 |
1.25 |
1.11 |
1.07 |
|
Adcy7 | |
NM_001037724 |
adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] |
KLA | .43 |
.39 |
.35 |
.32 |
.45 |
.72 |
.84 |
| ATP | .90 |
.84 |
.62 |
.41 |
.53 |
.42 |
.94 |
| KLA/ATP | .39 |
.34 |
.23 |
.17 |
.41 |
.34 |
.67 |
|
Adcy7 | |
NM_007406 |
adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] |
KLA | .51 |
.52 |
.48 |
.41 |
.59 |
.81 |
.99 |
| ATP | 1.01 |
1.02 |
.62 |
.52 |
.53 |
.38 |
.98 |
| KLA/ATP | .53 |
.48 |
.30 |
.27 |
.42 |
.36 |
.65 |
|
Adcy8 | |
NM_009623 |
adenylate cyclase 8 (Adcy8), mRNA [NM_009623] |
KLA | 1.00 |
1.00 |
1.07 |
.97 |
1.04 |
.98 |
1.02 |
| ATP | 1.04 |
1.05 |
1.14 |
1.03 |
.99 |
1.00 |
.97 |
| KLA/ATP | 1.05 |
1.04 |
1.00 |
1.03 |
.98 |
.94 |
.96 |
|
Adcy9 | |
NM_009624 |
adenylate cyclase 9 (Adcy9), mRNA [NM_009624] |
KLA | .18 |
.15 |
.13 |
.15 |
.17 |
.19 |
.33 |
| ATP | 1.33 |
1.16 |
.97 |
.98 |
.62 |
.56 |
.86 |
| KLA/ATP | .19 |
.16 |
.17 |
.18 |
.20 |
.25 |
.38 |
|
Aqp1 | |
NM_007472 |
aquaporin 1 (Aqp1), mRNA [NM_007472] |
KLA | 1.01 |
.93 |
.93 |
.97 |
.95 |
.91 |
.72 |
| ATP | .98 |
1.01 |
.95 |
.97 |
.90 |
.92 |
.78 |
| KLA/ATP | .95 |
.92 |
.93 |
.90 |
.93 |
.90 |
.73 |
|
Aqp4 | |
NM_009700 |
aquaporin 4 (Aqp4), mRNA [NM_009700] |
KLA | .99 |
1.01 |
.96 |
1.00 |
1.06 |
1.01 |
1.02 |
| ATP | .99 |
.99 |
1.05 |
1.08 |
1.00 |
1.02 |
1.03 |
| KLA/ATP | 1.01 |
1.00 |
1.00 |
1.01 |
.99 |
1.02 |
1.00 |
|
Aqp8 | |
NM_007474 |
aquaporin 8 (Aqp8), transcript variant 1, mRNA [NM_007474] |
KLA | .98 |
1.12 |
1.08 |
1.12 |
1.07 |
1.03 |
1.06 |
| ATP | .98 |
.97 |
.98 |
1.05 |
1.25 |
1.26 |
1.11 |
| KLA/ATP | 1.04 |
1.07 |
1.12 |
1.03 |
1.24 |
1.42 |
1.56 |
|
Aqp9 | |
NM_022026 |
aquaporin 9 (Aqp9), mRNA [NM_022026] |
KLA | 1.11 |
1.12 |
1.10 |
1.13 |
1.18 |
1.19 |
1.00 |
| ATP | .99 |
1.06 |
.99 |
1.00 |
1.29 |
1.46 |
1.24 |
| KLA/ATP | 1.08 |
1.08 |
1.07 |
1.18 |
1.25 |
1.55 |
2.05 |
|
Atp1a1 | |
NM_144900 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA [NM_144900] |
KLA | .78 |
.94 |
.68 |
.81 |
.62 |
.55 |
.75 |
| ATP | 1.02 |
1.05 |
.86 |
.85 |
1.77 |
2.54 |
1.11 |
| KLA/ATP | .83 |
.99 |
.80 |
.75 |
.91 |
1.15 |
.68 |
|
Atp1a2 | |
NM_178405 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide (Atp1a2), mRNA [NM_178405] |
KLA | 1.03 |
.98 |
1.03 |
1.05 |
1.03 |
.98 |
1.02 |
| ATP | 1.03 |
.98 |
1.06 |
1.05 |
1.05 |
.93 |
1.07 |
| KLA/ATP | 1.04 |
1.05 |
1.02 |
1.02 |
.98 |
.92 |
1.02 |
|
Atp1a3 | |
AK053751 |
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130306P09 product:ATPase, Na+/K+ transporting, alpha 3 polypeptide, full insert sequence. [AK053751] |
KLA | .88 |
.87 |
.74 |
.80 |
.84 |
.88 |
.93 |
| ATP | .96 |
.83 |
.80 |
.88 |
.94 |
.89 |
1.15 |
| KLA/ATP | .89 |
.86 |
.79 |
.90 |
.93 |
.84 |
.92 |
|
Atp1a3 | |
NM_144921 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide (Atp1a3), mRNA [NM_144921] |
KLA | .99 |
.87 |
.96 |
.86 |
.81 |
.61 |
.52 |
| ATP | 1.22 |
1.21 |
1.16 |
1.38 |
1.27 |
.92 |
1.30 |
| KLA/ATP | .96 |
1.10 |
1.17 |
1.42 |
1.11 |
.91 |
.93 |
|
Atp1b1 | |
NM_009721 |
ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721] |
KLA | .97 |
1.02 |
1.08 |
.98 |
.95 |
1.01 |
1.09 |
| ATP | 1.07 |
1.05 |
1.09 |
1.09 |
1.02 |
1.17 |
1.11 |
| KLA/ATP | .99 |
.99 |
.93 |
1.02 |
1.00 |
1.07 |
1.04 |
|
Atp1b2 | |
NM_013415 |
ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2), mRNA [NM_013415] |
KLA | 1.18 |
1.09 |
1.11 |
1.12 |
1.16 |
1.12 |
1.15 |
| ATP | .95 |
.98 |
.99 |
1.26 |
1.06 |
1.10 |
1.07 |
| KLA/ATP | 1.15 |
1.16 |
1.09 |
1.19 |
1.27 |
1.13 |
1.02 |
|
Atp1b3 | |
NM_007502 |
ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA [NM_007502] |
KLA | 1.86 |
2.10 |
2.25 |
2.21 |
2.68 |
3.26 |
3.45 |
| ATP | 1.08 |
1.09 |
.93 |
1.13 |
1.55 |
2.14 |
2.38 |
| KLA/ATP | 1.95 |
2.10 |
1.84 |
2.34 |
2.20 |
2.96 |
4.69 |
|
Atp1b4 | |
NM_133690 |
ATPase, (Na+)/K+ transporting, beta 4 polypeptide (Atp1b4), mRNA [NM_133690] |
KLA | .99 |
1.02 |
1.03 |
1.01 |
.95 |
.90 |
1.00 |
| ATP | 1.00 |
1.05 |
1.04 |
.98 |
1.07 |
.98 |
.97 |
| KLA/ATP | 1.00 |
1.05 |
1.03 |
1.04 |
.96 |
.97 |
1.01 |
|
Baat | |
NM_007519 |
bile acid-Coenzyme A: amino acid N-acyltransferase (Baat), mRNA [NM_007519] |
KLA | .98 |
.99 |
1.01 |
.95 |
.97 |
.97 |
1.01 |
| ATP | .97 |
.97 |
1.01 |
.99 |
1.12 |
1.01 |
1.00 |
| KLA/ATP | 1.02 |
1.04 |
1.00 |
1.05 |
1.10 |
.99 |
1.01 |
|
Car2 | |
NM_009801 |
carbonic anhydrase 2 (Car2), mRNA [NM_009801] |
KLA | 9.50 |
10.18 |
12.25 |
12.70 |
14.42 |
16.57 |
6.38 |
| ATP | .98 |
.97 |
1.35 |
1.55 |
3.60 |
9.36 |
8.47 |
| KLA/ATP | 8.20 |
10.30 |
10.62 |
13.18 |
12.35 |
14.45 |
22.78 |
|
Cftr | |
NM_021050 |
cystic fibrosis transmembrane conductance regulator homolog (Cftr), mRNA [NM_021050] |
KLA | 1.00 |
1.01 |
1.00 |
1.00 |
1.01 |
1.01 |
1.03 |
| ATP | 1.01 |
.99 |
.99 |
1.02 |
.99 |
.99 |
1.01 |
| KLA/ATP | 1.03 |
1.01 |
.99 |
.99 |
.98 |
1.02 |
1.01 |
|
Cyp7a1 | |
NM_007824 |
cytochrome P450, family 7, subfamily a, polypeptide 1 (Cyp7a1), mRNA [NM_007824] |
KLA | 1.03 |
.99 |
.97 |
1.00 |
.97 |
1.03 |
.99 |
| ATP | .99 |
.99 |
1.02 |
1.04 |
.99 |
.99 |
1.03 |
| KLA/ATP | 1.03 |
1.00 |
.99 |
.99 |
.91 |
.97 |
.99 |
|
Ephx1 | |
NM_010145 |
epoxide hydrolase 1, microsomal (Ephx1), mRNA [NM_010145] |
KLA | .90 |
.97 |
.94 |
.80 |
.69 |
.47 |
.19 |
| ATP | 1.10 |
1.20 |
1.02 |
1.41 |
1.02 |
.63 |
.23 |
| KLA/ATP | 1.09 |
1.04 |
.83 |
1.21 |
.78 |
.58 |
.29 |
|
Fxyd2 | |
NM_052823 |
FXYD domain-containing ion transport regulator 2 (Fxyd2), transcript variant b, mRNA [NM_052823] |
KLA | 1.07 |
.97 |
1.09 |
.98 |
1.02 |
.96 |
.83 |
| ATP | 1.07 |
1.22 |
1.00 |
1.14 |
1.00 |
1.22 |
4.11 |
| KLA/ATP | 1.06 |
1.11 |
.96 |
1.13 |
.98 |
1.01 |
1.02 |
|
Gnas | |
AF107847 |
neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] |
KLA | 1.04 |
.94 |
1.00 |
1.05 |
1.04 |
.98 |
1.00 |
| ATP | .98 |
.97 |
.96 |
1.00 |
.99 |
.98 |
1.02 |
| KLA/ATP | 1.04 |
1.02 |
.96 |
.95 |
1.01 |
.96 |
1.01 |
|
Gnas | |
AK017423 |
10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] |
KLA | .85 |
1.08 |
.97 |
.92 |
1.05 |
1.03 |
1.08 |
| ATP | .99 |
1.30 |
2.11 |
1.73 |
1.23 |
1.01 |
1.02 |
| KLA/ATP | .96 |
1.06 |
1.58 |
1.34 |
1.29 |
1.05 |
.91 |
|
Gnas | |
NM_001077510 |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] |
KLA | .99 |
1.03 |
.97 |
.91 |
1.03 |
.95 |
.97 |
| ATP | 1.04 |
1.19 |
1.15 |
1.61 |
1.24 |
.91 |
1.00 |
| KLA/ATP | 1.06 |
.97 |
1.01 |
1.46 |
1.04 |
.85 |
1.01 |
|
Gnas | |
S49980 |
gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] |
KLA | .91 |
.88 |
1.03 |
.87 |
.90 |
.84 |
1.01 |
| ATP | 1.16 |
1.22 |
1.02 |
1.55 |
1.16 |
.80 |
.99 |
| KLA/ATP | 1.01 |
1.13 |
.86 |
1.12 |
.97 |
.85 |
1.08 |
|
Hmgcr | |
NM_008255 |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase (Hmgcr), mRNA [NM_008255] |
KLA | 2.15 |
2.09 |
2.02 |
1.44 |
1.13 |
.88 |
1.02 |
| ATP | 1.05 |
1.16 |
1.43 |
1.53 |
1.83 |
2.60 |
1.87 |
| KLA/ATP | 2.16 |
2.23 |
1.99 |
1.81 |
1.34 |
1.81 |
1.79 |
|
Kcnn2 | |
NM_080465 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 (Kcnn2), mRNA [NM_080465] |
KLA | 1.00 |
1.02 |
1.00 |
1.03 |
1.02 |
1.01 |
1.01 |
| ATP | 1.00 |
1.00 |
1.02 |
1.01 |
1.01 |
1.01 |
1.02 |
| KLA/ATP | .99 |
1.02 |
1.01 |
1.01 |
1.02 |
.99 |
1.00 |
|
Ldlr | |
NM_010700 |
low density lipoprotein receptor (Ldlr), mRNA [NM_010700] |
KLA | 2.17 |
2.00 |
2.07 |
1.87 |
1.38 |
.78 |
1.00 |
| ATP | .98 |
.87 |
1.53 |
1.14 |
1.01 |
1.52 |
1.60 |
| KLA/ATP | 1.86 |
1.76 |
2.52 |
1.55 |
1.59 |
.84 |
.82 |
|
Ldlr | |
Z19521 |
gb|M.musculus Ldlr mRNA encoding low density lipoprotein receptor. [Z19521] |
KLA | 1.94 |
1.93 |
2.24 |
2.01 |
1.73 |
1.08 |
1.26 |
| ATP | 1.12 |
1.21 |
1.47 |
1.65 |
1.28 |
1.45 |
1.67 |
| KLA/ATP | 2.22 |
2.28 |
2.17 |
2.27 |
1.50 |
1.13 |
1.29 |
|
Mm.10984
| |
6678010 |
Unknown |
KLA | .98 |
1.03 |
.96 |
1.03 |
.98 |
.98 |
.98 |
| ATP | .96 |
.96 |
1.01 |
1.06 |
.93 |
.93 |
.93 |
| KLA/ATP | .96 |
.93 |
.84 |
.93 |
1.08 |
1.19 |
1.04 |
|
Mm.20735 4 | |
153791546 |
Unknown |
KLA | 2.55 |
2.91 |
3.13 |
3.94 |
2.81 |
2.17 |
.88 |
| ATP | .94 |
.94 |
1.06 |
1.06 |
1.56 |
3.88 |
1.30 |
| KLA/ATP | 2.25 |
2.53 |
2.66 |
1.89 |
2.08 |
3.58 |
1.89 |
|
Mm.25237
| |
141802859 |
Unknown |
KLA | 1.03 |
1.07 |
1.05 |
1.08 |
1.02 |
1.02 |
1.00 |
| ATP | .98 |
1.02 |
.89 |
.99 |
.99 |
1.03 |
1.09 |
| KLA/ATP | .92 |
.94 |
1.11 |
1.03 |
1.02 |
.97 |
1.09 |
|
Mm.3095 | |
6677830 |
Unknown |
KLA | 1.02 |
.98 |
1.00 |
1.03 |
.98 |
1.02 |
.97 |
| ATP | 1.03 |
.99 |
1.05 |
.99 |
.95 |
.95 |
1.04 |
| KLA/ATP | 1.07 |
1.07 |
1.04 |
.98 |
.96 |
1.03 |
1.25 |
|
Mm.40537
| |
142358785 |
Unknown |
KLA | 1.04 |
1.06 |
1.08 |
1.02 |
1.04 |
1.10 |
.93 |
| ATP | .87 |
.87 |
1.14 |
.90 |
.72 |
1.19 |
.52 |
| KLA/ATP | .96 |
1.04 |
1.15 |
.88 |
.77 |
.67 |
.47 |
|
Mm.41137
| |
148747308 |
Unknown |
KLA | 1.03 |
1.00 |
.95 |
.92 |
1.04 |
.98 |
.96 |
| ATP | 1.02 |
.98 |
.98 |
.90 |
.95 |
.92 |
1.07 |
| KLA/ATP | .91 |
.89 |
1.01 |
.95 |
1.00 |
.96 |
.99 |
|
Mm.45858 3 | |
13507613 |
Unknown |
KLA | 1.01 |
1.03 |
.97 |
1.04 |
.99 |
1.04 |
1.00 |
| ATP | 1.03 |
1.07 |
1.01 |
.97 |
.99 |
1.06 |
1.02 |
| KLA/ATP | .99 |
1.00 |
1.01 |
.96 |
1.05 |
1.04 |
.97 |
|
Nr0b2 | |
NM_011850 |
nuclear receptor subfamily 0, group B, member 2 (Nr0b2), mRNA [NM_011850] |
KLA | .84 |
.88 |
.90 |
.82 |
.87 |
.83 |
.91 |
| ATP | .99 |
1.05 |
.95 |
.93 |
.84 |
.87 |
.82 |
| KLA/ATP | .86 |
.88 |
.89 |
.85 |
.80 |
.91 |
.85 |
|
Nr1h4 | |
NM_009108 |
nuclear receptor subfamily 1, group H, member 4 (Nr1h4), mRNA [NM_009108] |
KLA | 1.08 |
1.06 |
1.02 |
1.02 |
1.02 |
1.02 |
1.02 |
| ATP | .92 |
1.00 |
1.09 |
.97 |
.96 |
.97 |
1.04 |
| KLA/ATP | 1.01 |
.97 |
1.08 |
.99 |
.99 |
1.08 |
1.42 |
|
Osta | |
AK147155 |
cDNA, RIKEN full-length enriched library, clone:I920191F06 product:similar to Organic solute transporter alpha [Homo sapiens], full insert sequence [AK147155] |
KLA | 1.02 |
.99 |
.98 |
.92 |
1.11 |
.94 |
.97 |
| ATP | .98 |
1.01 |
.92 |
1.02 |
.95 |
1.03 |
1.00 |
| KLA/ATP | .97 |
1.03 |
1.03 |
1.05 |
.99 |
1.00 |
.99 |
|
Osta | |
NM_145932 |
organic solute transporter alpha (Osta), mRNA [NM_145932] |
KLA | 1.01 |
.94 |
1.03 |
.99 |
.97 |
.93 |
.99 |
| ATP | 1.03 |
.95 |
1.00 |
.94 |
1.03 |
.99 |
1.01 |
| KLA/ATP | 1.01 |
.92 |
1.03 |
.96 |
1.04 |
.90 |
.97 |
|
Ostb | |
NM_178933 |
organic solute transporter beta (Ostb), mRNA [NM_178933] |
KLA | .99 |
.94 |
1.02 |
.96 |
.97 |
.99 |
1.00 |
| ATP | .96 |
.96 |
.98 |
.95 |
.99 |
.85 |
.98 |
| KLA/ATP | .91 |
1.01 |
.94 |
.95 |
.96 |
.98 |
1.01 |
|
Prkaca | |
NM_008854 |
protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] |
KLA | .71 |
.74 |
.72 |
.70 |
.72 |
.84 |
.85 |
| ATP | 1.05 |
.98 |
.89 |
.92 |
.76 |
.60 |
1.02 |
| KLA/ATP | .79 |
.74 |
.55 |
.65 |
.60 |
.65 |
.93 |
|
Prkacb | |
NM_011100 |
protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] |
KLA | .69 |
.70 |
.66 |
.58 |
.51 |
.55 |
.59 |
| ATP | 1.02 |
1.19 |
.97 |
1.01 |
.69 |
.38 |
.56 |
| KLA/ATP | .72 |
.73 |
.57 |
.62 |
.47 |
.41 |
.45 |
|
Prkx | |
NM_016979 |
protein kinase, X-linked (Prkx), mRNA [NM_016979] |
KLA | 3.61 |
3.79 |
4.67 |
4.66 |
4.85 |
4.19 |
1.43 |
| ATP | .98 |
.90 |
.63 |
.61 |
1.12 |
1.90 |
1.29 |
| KLA/ATP | 3.56 |
3.36 |
2.62 |
2.06 |
2.26 |
2.87 |
2.31 |
|
Rxra | |
NM_011305 |
retinoid X receptor alpha (Rxra), mRNA [NM_011305] |
KLA | .53 |
.55 |
.50 |
.52 |
.54 |
.85 |
1.09 |
| ATP | .95 |
1.00 |
1.18 |
1.00 |
.82 |
1.20 |
1.65 |
| KLA/ATP | .57 |
.55 |
.58 |
.55 |
.67 |
1.07 |
1.57 |
|
Scarb1 | |
NM_016741 |
scavenger receptor class B, member 1 (Scarb1), mRNA [NM_016741] |
KLA | .62 |
.60 |
.60 |
.51 |
.45 |
.40 |
.48 |
| ATP | 1.04 |
1.14 |
.68 |
.89 |
.53 |
.46 |
.82 |
| KLA/ATP | .73 |
.67 |
.40 |
.55 |
.34 |
.30 |
.39 |
|
Sctr | |
NM_001012322 |
secretin receptor (Sctr), mRNA [NM_001012322] |
KLA | .96 |
.94 |
1.01 |
1.01 |
1.02 |
.94 |
.99 |
| ATP | 1.06 |
.97 |
.99 |
.95 |
1.02 |
.99 |
.98 |
| KLA/ATP | 1.03 |
1.07 |
.99 |
1.07 |
.94 |
.99 |
1.00 |
|
Slc10a1 | |
NM_011387 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 (Slc10a1), mRNA [NM_011387] |
KLA | .98 |
.98 |
.99 |
1.01 |
1.05 |
.95 |
.99 |
| ATP | .98 |
.96 |
1.04 |
.99 |
.95 |
.93 |
1.03 |
| KLA/ATP | .89 |
.97 |
1.05 |
.96 |
1.03 |
1.02 |
1.03 |
|
Slc10a2 | |
NM_011388 |
solute carrier family 10, member 2 (Slc10a2), mRNA [NM_011388] |
KLA | 1.03 |
1.02 |
1.01 |
1.01 |
1.01 |
1.06 |
1.05 |
| ATP | 1.04 |
1.02 |
1.03 |
.99 |
.99 |
1.08 |
1.06 |
| KLA/ATP | 1.00 |
.98 |
1.04 |
1.07 |
1.10 |
.99 |
.98 |
|
Slc22a1 | |
NM_009202 |
solute carrier family 22 (organic cation transporter), member 1 (Slc22a1), mRNA [NM_009202] |
KLA | 1.11 |
1.10 |
1.06 |
1.02 |
.97 |
1.05 |
.97 |
| ATP | 1.00 |
1.00 |
1.06 |
1.45 |
1.28 |
.99 |
.97 |
| KLA/ATP | 1.02 |
1.02 |
1.07 |
1.07 |
1.13 |
1.07 |
1.08 |
|
Slc22a7 | |
NM_144856 |
solute carrier family 22 (organic anion transporter), member 7 (Slc22a7), mRNA [NM_144856] |
KLA | 1.05 |
1.00 |
.96 |
.95 |
.95 |
1.02 |
1.05 |
| ATP | .90 |
.95 |
1.03 |
1.07 |
1.01 |
.94 |
.98 |
| KLA/ATP | .98 |
.98 |
1.01 |
.96 |
.92 |
1.03 |
1.02 |
|
Slc22a8 | |
NM_031194 |
solute carrier family 22 (organic anion transporter), member 8 (Slc22a8), mRNA [NM_031194] |
KLA | 1.04 |
1.03 |
1.02 |
1.06 |
1.06 |
1.03 |
1.05 |
| ATP | .98 |
1.03 |
.99 |
1.02 |
.99 |
1.03 |
1.02 |
| KLA/ATP | .99 |
1.01 |
1.04 |
1.00 |
1.05 |
.99 |
1.04 |
|
Slc27a5 | |
NM_009512 |
solute carrier family 27 (fatty acid transporter), member 5 (Slc27a5), mRNA [NM_009512] |
KLA | .94 |
.95 |
.95 |
1.02 |
1.03 |
.97 |
1.02 |
| ATP | 1.03 |
.95 |
1.04 |
1.10 |
.97 |
.91 |
1.00 |
| KLA/ATP | 1.06 |
.96 |
.94 |
.99 |
1.04 |
1.01 |
1.04 |
|
Slc2a1 | |
NM_011400 |
solute carrier family 2 (facilitated glucose transporter), member 1 (Slc2a1), mRNA [NM_011400] |
KLA | 1.31 |
1.46 |
1.10 |
1.68 |
1.75 |
1.95 |
2.34 |
| ATP | .88 |
.90 |
1.32 |
1.99 |
3.40 |
10.49 |
1.93 |
| KLA/ATP | 1.13 |
1.25 |
1.71 |
2.14 |
3.71 |
6.31 |
4.63 |
|
Slc4a2 | |
NM_009207 |
solute carrier family 4 (anion exchanger), member 2 (Slc4a2), mRNA [NM_009207] |
KLA | .96 |
.89 |
1.01 |
.78 |
.99 |
.85 |
.89 |
| ATP | 1.26 |
1.27 |
.48 |
.61 |
.70 |
.78 |
1.49 |
| KLA/ATP | 1.18 |
1.11 |
.49 |
.63 |
.67 |
.69 |
1.52 |
|
Slc4a4 | |
NM_018760 |
solute carrier family 4 (anion exchanger), member 4 (Slc4a4), mRNA [NM_018760] |
KLA | 1.02 |
1.03 |
1.01 |
1.02 |
.98 |
1.01 |
1.01 |
| ATP | 1.03 |
.97 |
.94 |
1.00 |
1.02 |
1.00 |
1.02 |
| KLA/ATP | 1.02 |
1.04 |
.85 |
1.03 |
.98 |
.97 |
1.00 |
|
Slc4a5 | |
AK049248 |
ES cells cDNA, RIKEN full-length enriched library, clone:C330016K18 product:similar to SODIUM BICARBONATE COTRANSPORTER ISOFORM 1 (FRAGMENT) [Canis familiaris], full insert sequence. [AK049248] |
KLA | .92 |
.97 |
1.03 |
1.03 |
.95 |
1.00 |
.98 |
| ATP | 1.00 |
1.02 |
1.04 |
1.02 |
.94 |
.99 |
.92 |
| KLA/ATP | .96 |
.93 |
1.06 |
.95 |
.98 |
.94 |
.94 |
|
Slc4a5 | |
XM_888058 |
gb|PREDICTED: Mus musculus RIKEN cDNA C330016K18 gene, transcript variant 3 (C330016K18Rik), mRNA [XM_888058] |
KLA | .94 |
1.02 |
1.04 |
.98 |
.98 |
.96 |
.99 |
| ATP | 1.03 |
1.00 |
.99 |
.95 |
.97 |
.94 |
.96 |
| KLA/ATP | 1.00 |
1.05 |
1.02 |
.96 |
.99 |
.95 |
1.00 |
|
Slc5a1 | |
NM_019810 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 (Slc5a1), mRNA [NM_019810] |
KLA | 1.02 |
1.02 |
1.03 |
1.04 |
.99 |
.93 |
1.06 |
| ATP | 1.03 |
1.03 |
1.02 |
1.05 |
1.04 |
.98 |
.97 |
| KLA/ATP | 1.02 |
.94 |
1.02 |
1.03 |
1.03 |
1.04 |
1.02 |
|
Slc9a1 | |
NM_016981 |
solute carrier family 9 (sodium/hydrogen exchanger), member 1 (Slc9a1), mRNA [NM_016981] |
KLA | 1.74 |
1.72 |
1.95 |
1.84 |
1.86 |
1.53 |
1.49 |
| ATP | 1.11 |
1.28 |
.95 |
1.46 |
1.98 |
2.67 |
1.47 |
| KLA/ATP | 1.85 |
2.02 |
1.70 |
2.47 |
2.18 |
3.18 |
3.48 |
|
Slc9a1 | |
U51112 |
Na+/H+ exchanger (NHE-1) mRNA, complete cds. [U51112] |
KLA | 1.78 |
1.83 |
2.11 |
1.90 |
1.91 |
1.61 |
1.40 |
| ATP | 1.07 |
1.14 |
.98 |
1.54 |
2.00 |
2.85 |
1.44 |
| KLA/ATP | 1.97 |
2.16 |
2.01 |
2.44 |
2.30 |
3.37 |
3.15 |
|
Slc9a3 | |
AK033564 |
adult male colon cDNA, RIKEN full-length enriched library, clone:9030624O13 product:SODIUM [AK033564] |
KLA | .96 |
.94 |
.91 |
.97 |
.95 |
1.03 |
.99 |
| ATP | 1.06 |
1.02 |
1.01 |
.95 |
.90 |
.95 |
1.08 |
| KLA/ATP | .97 |
.91 |
.93 |
.95 |
1.02 |
1.03 |
1.01 |
|
Slco1a1 | |
AF223067 |
organic anion transporting polypeptide 1 (Oatp1) mRNA, complete cds. [AF223067] |
KLA | 1.02 |
.98 |
.99 |
.95 |
1.05 |
1.00 |
.99 |
| ATP | 1.01 |
1.03 |
1.01 |
1.11 |
1.01 |
1.03 |
1.06 |
| KLA/ATP | 1.03 |
1.00 |
.98 |
1.01 |
1.06 |
1.05 |
.98 |
|
Slco1a1 | |
AY195869 |
strain CAST [AY195869] |
KLA | 1.09 |
.98 |
.93 |
1.03 |
1.00 |
.98 |
1.08 |
| ATP | 1.00 |
.96 |
1.03 |
1.04 |
.99 |
1.02 |
1.00 |
| KLA/ATP | 1.00 |
1.04 |
1.05 |
1.06 |
1.01 |
1.08 |
1.08 |
|
Slco1a4 | |
NM_030687 |
solute carrier organic anion transporter family, member 1a4 (Slco1a4), mRNA [NM_030687] |
KLA | .97 |
.98 |
1.15 |
.94 |
1.04 |
1.04 |
.97 |
| ATP | 1.00 |
.97 |
.97 |
.93 |
1.06 |
.96 |
1.03 |
| KLA/ATP | 1.04 |
1.01 |
1.03 |
.91 |
1.02 |
1.02 |
.96 |
|
Slco1a5 | |
NM_130861 |
solute carrier organic anion transporter family, member 1a5 (Slco1a5), mRNA [NM_130861] |
KLA | .98 |
.99 |
.97 |
1.01 |
.98 |
1.04 |
1.02 |
| ATP | 1.00 |
.98 |
1.05 |
1.05 |
.97 |
1.05 |
1.01 |
| KLA/ATP | .96 |
1.01 |
.99 |
1.01 |
1.04 |
1.07 |
.98 |
|
Slco1a6 | |
NM_023718 |
solute carrier organic anion transporter family, member 1a6 (Slco1a6), mRNA [NM_023718] |
KLA | 1.00 |
1.01 |
.94 |
.91 |
1.01 |
1.01 |
1.00 |
| ATP | .96 |
1.04 |
1.08 |
.99 |
1.00 |
1.03 |
1.05 |
| KLA/ATP | 1.03 |
.94 |
.97 |
1.00 |
1.11 |
.97 |
1.00 |
|
Slco1b2 | |
NM_178235 |
solute carrier organic anion transporter family, member 1b2 (Slco1b2), transcript variant 2, mRNA [NM_178235] |
KLA | 1.01 |
1.03 |
1.06 |
.99 |
.92 |
1.04 |
1.03 |
| ATP | 1.00 |
.93 |
.98 |
.93 |
.96 |
.96 |
.98 |
| KLA/ATP | 1.00 |
.98 |
1.00 |
1.06 |
.91 |
.95 |
1.00 |
|